Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma
Yixin Zhao, Heping Zhao, Mengyao Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 20, pp. 2638-2656
Open Access | Times Cited: 11
Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring
Wenqian Wang, Shan-Shan Zhen, Ping Yu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence
Pierfrancesco Visaggi, Brigida Barberio, Matteo Ghisa, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3162-3162
Open Access | Times Cited: 49
Protective Effects of Dexmedetomidine on Sepsis-Induced Vascular Leakage by Alleviating Ferroptosis via Regulating Metabolic Reprogramming
Han She, Yi Hu, Yuanqun Zhou, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6765-6782
Open Access | Times Cited: 48
Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma
Qingfu Zhu, Liu Huang, Qinsi Yang, et al.
Nanoscale (2021) Vol. 13, Iss. 39, pp. 16457-16464
Closed Access | Times Cited: 43
Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
Pan Pan Wang, Xin Song, Xue Ke Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies
Xue-Man Dong, Lin Chen, Yuxin Xu, et al.
Cancer Gene Therapy (2025)
Closed Access
Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research
Ning Yu, Ruirui Wang, Baocheng Liu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 16
Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer
Jiahui Feng, Zhizhong Gong, Zhangran Sun, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9
Purine salvage–associated metabolites as biomarkers for early diagnosis of esophageal squamous cell carcinoma: a diagnostic model–based study
Yawen Sun, Wenjuan Liu, Mu Su, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma
Xia Li, Lihong Zhao, Mengke Wei, et al.
Journal of Cancer (2021) Vol. 12, Iss. 11, pp. 3190-3197
Open Access | Times Cited: 21
A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma
Jinhui Zhao, Xinshu Zhao, Jiaying Yu, et al.
Analytica Chimica Acta (2022) Vol. 1220, pp. 340038-340038
Closed Access | Times Cited: 13
Identification of organic pollutants and heavy metals in natural rubber wastewater and evaluation its phytotoxicity and cytogenotoxicity
Dayu Zhu, Chengjun Ge, Ying Sun, et al.
Chemosphere (2023) Vol. 349, pp. 140503-140503
Closed Access | Times Cited: 7
Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
Mengying Cui, Xing Yi, Zhenzhen Cao, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-27
Open Access | Times Cited: 9
Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances
Xiao Mou, Zhenglin Peng, Tao Yin, et al.
Journal of Gastrointestinal Cancer (2023) Vol. 55, Iss. 1, pp. 118-128
Closed Access | Times Cited: 5
A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma
Jiali Lv, Jialin Wang, Xiaotao Shen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 11
Prediction of Fuhrman nuclear grade for clear cell renal carcinoma by a multi-information fusion model that incorporates CT-based features of tumor and serum tumor associated material
Yumei Zhang, Zehua Sun, Heng Ma, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 17, pp. 15855-15865
Closed Access | Times Cited: 4
Metabolomics for searching validated biomarkers in cancer studies: a decade in review
Ángeles López-López, Ángeles López‐Gonzálvez, Coral Barbas
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 7, pp. 601-626
Closed Access | Times Cited: 1
The Molecular Mechanism of Mycelial Incubation Time Effects on Primordium Formation of Pleurotus tuoliensis Through Transcriptome and Lipidomic Analyses
Qi He, Chenyang Huang, Lijiao Zhang, et al.
Agriculture (2024) Vol. 14, Iss. 12, pp. 2277-2277
Open Access | Times Cited: 1
Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
Mengjie Yu, Wei Wen, Xin Yi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Protective effects of mitochondrial fission inhibition on ox-LDL induced VSMC foaming via metabolic reprogramming
Yijin Fang, Yu Zhu, Yue Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation
Dariush Nasrollahzadeh, Gholamreza Roshandel, Tiffany M. Delhomme, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5627-5627
Open Access | Times Cited: 7
Metabolic signatures and potential biomarkers for the diagnosis and treatment of colon cancer cachexia
Xu Qiu, Ruohan Lu, Qiqing He, et al.
Acta Biochimica et Biophysica Sinica (2023)
Open Access | Times Cited: 2
Construction and validation of serum Metabolic Risk Score for early warning of malignancy in esophagus
Mengfei Liu, Hongrui Tian, Minmin Wang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109965-109965
Open Access
Current status and perspectives of esophageal cancer: a comprehensive review
Wei Jiang, Bo Zhang, Jiaqi Xu, et al.
Cancer Communications (2024)
Open Access
Page 1 - Next Page

Scroll to top